Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

No reported EBITDA figures are available to summarize.

EBITDA history

Currency unavailable · from the income statement

No EBITDA data reported for this period type.

EBITDA vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
EBITDA for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$85.88M USD+54.7%—30.5%
ANABAnaptysBio, Inc.LTM Mar 2026$58.49M USD+176.6%—25.2%
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024-€45.89M EUR-286.3%——
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-$70.61M USD-31.5%—843.9%
IMUXImmunic, Inc.LTM Mar 2026-$104.13M USD-8.2%——
ORKAOruka Therapeutics, Inc.LTM Sep 2026-$161.31M USD-42.5%——
SYRESpyre Therapeutics, Inc.LTM Sep 2026-$280.09M USD-70.6%—309.5%
ALMSAlumis Inc. Common StockLTM Jun 2026-$442.87M USD-9.5%—5986.3%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-20.5%—309.5%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.